HomeCompareCGXYY vs MRK

CGXYY vs MRK: Dividend Comparison 2026

CGXYY yields 3.21% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CGXYY wins by $583.89M in total portfolio value
10 years
CGXYY
CGXYY
● Live price
3.21%
Share price
$31.98
Annual div
$1.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$583.95M
Annual income
$551,014,462.81
Full CGXYY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CGXYY vs MRK

📍 CGXYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGXYYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGXYY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CGXYY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGXYY
Annual income on $10K today (after 15% tax)
$273.18/yr
After 10yr DRIP, annual income (after tax)
$468,362,293.39/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CGXYY beats the other by $468,353,964.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGXYY + MRK for your $10,000?

CGXYY: 50%MRK: 50%
100% MRK50/50100% CGXYY
Portfolio after 10yr
$292.00M
Annual income
$275,512,130.47/yr
Blended yield
94.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CGXYY
No analyst data
Altman Z
0.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGXYY buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGXYYMRK
Forward yield3.21%2.76%
Annual dividend / share$1.03$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$583.95M$56.8K
Annual income after 10y$551,014,462.81$9,798.13
Total dividends collected$581.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CGXYY vs MRK ($10,000, DRIP)

YearCGXYY PortfolioCGXYY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,343$642.78$11,206$366.19+$137.00CGXYY
2$13,500$1,362.78$12,650$502.35+$850.00CGXYY
3$17,476$3,031.60$14,407$694.19+$3.1KCGXYY
4$26,035$7,335.74$16,585$967.82+$9.4KCGXYY
5$48,285$20,427.05$19,342$1,363.89+$28.9KCGXYY
6$122,476$70,811.01$22,913$1,947.19+$99.6KCGXYY
7$466,777$335,727.71$27,662$2,823.89+$439.1KCGXYY
8$2,891,074$2,391,623.39$34,159$4,173.35+$2.86MCGXYY
9$30,781,295$27,687,845.37$43,337$6,308.80+$30.74MCGXYY
10$583,950,448$551,014,462.81$56,776$9,798.13+$583.89MCGXYY

CGXYY vs MRK: Complete Analysis 2026

CGXYYStock

China Galaxy Securities Co., Ltd. provides various financial services in the People's Republic of China. Its Securities Brokerage segment offers securities dealing and broking; margin financing to margin clients; and securities lending services. The Company's Futures Brokerage segment is involved in futures dealing and broking, futures information consulting, and training activities. Its Proprietary Trading and Other Securities Trading Services segment engages in trading of equities, bonds, funds, derivatives, and other financial products. The Company's Investment Banking segment provides corporate financial services, including equity and debt securities underwriting, and financial advisory services to institutional clients. Its Asset Management segment offers portfolio management, investment advisory, and transaction execution services. The Company's Private Equity and Alternative Investment segment provides equity investments in private companies. Its Overseas Business segment offers securities and futures brokerage, securities research, investment banking, margin financing, money lending, asset management, and insurance brokerage services. The company serves various individual and institutional clients comprising multinational corporations, medium and small-sized enterprises, high-net-worth clients, and retail clients. As of December 31, 2021, it operated through a network of 37 branch offices and 501 securities branches. The company was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China. China Galaxy Securities Co., Ltd. operates as a subsidiary of China Galaxy Financial Holdings Company Limited.

Full CGXYY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CGXYY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGXYY vs SCHDCGXYY vs JEPICGXYY vs OCGXYY vs KOCGXYY vs MAINCGXYY vs JNJCGXYY vs ABBVCGXYY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.